Resuming hip and knee arthroplasty after COVID-19: ethical implications for wellbeing, safety and the economy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32635761.
- Also identified by DOI 10.1177/1120700020941232 and PMC identifier 7345437.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Reinstating elective hip and knee arthroplasty services presents significant challenges. We need to be honest about the scale of the obstacles ahead and realise that the health challenges and economic consequences of the COVID-19 pandemic are potentially devastating.We must also prepare to make difficult ethical decisions about restarting elective hip and knee arthroplasty. These decisions should be based on the existing evidence-base, reliable data, the recommendations of experts, and regional circumstances.
Medical subject headings
- Arthroplasty, Replacement, Hip
- Arthroplasty, Replacement, Knee
- Betacoronavirus
- Coronavirus Infections
- Delivery of Health Care
- Pneumonia, Viral
Anatomy
- hip
- knee